- €140.60m
- €432.26m
- €765.08m
- 71
- 90
- 91
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.89 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -14.4% | ||
| Dividend Yield (f) | 4.71% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.63 | ||
| Price to Tang. Book | 0.71 | ||
| Price to Free Cashflow | 3.92 | ||
| Price to Sales | 0.18 | ||
| EV to EBITDA | 4.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.23% | ||
| Return on Equity | 11.87% | ||
| Operating Margin | 6.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 670.99 | 687.08 | 722.32 | 766.75 | 765.08 | 773.11 | 783.7 | 2.19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +545.92 | n/a | n/a | -21.52 | +5.05 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MediClin AG is a Germany-based company. The Company is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. It focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
Directors
- Jan Liersch CSU
- Volker Hippler CMG
- Hans Hilpert VSU
- Tino Fritz CFO (44)
- Michael Bock SUB
- Barbara Brosius SUB
- Julia Dannath-schuh SUB
- Walburga Erichsmeier SUB
- Kai Hankeln SUB
- Rainer Laufs SUB
- Thomas Mueller SUB (56)
- Elke Schwan SUB
- Frauke Schwedt SUB
- Daniela Sternberg-kinzel SUB
- Marco Walker SUB
- Matthias Werner SUB
- Thomas Witt SUB
- Cornelia Wolf SUB
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 18th, 1996
- Public Since
- December 4th, 2000
- No. of Employees
- 6,889
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
XETRA- Shares in Issue
- 47,500,000
- Address
- Okenstr. 27, OFFENBURG, 77652
- Web
- https://www.mediclin.de/
- Phone
- +49 7814880
- Auditors
- PricewaterhouseCoopers GmbH
Upcoming Events for MED
Dividend For MEDG.DE - 0.0400 EUR
Mediclin AG Annual Shareholders Meeting
Q2 2025 Mediclin AG Earnings Release
Similar to MED
Doccheck AG
XETRA
FamiCord AG
XETRA
FAQ
What is the MEDICLIN AG share price?
As of Today at 21:58 UTC, shares in MEDICLIN AG are trading at €2.96. This share price information is delayed by 15 minutes.
How has the MEDICLIN AG share price performed this year?
Shares in MEDICLIN AG last closed at €2.96 and the price had moved by +4.96% over the past 365 days. In terms of relative price strength the MEDICLIN AG share price has outperformed the FTSE Global All Cap Index by +2.34% over the past year.
What are the analyst and broker recommendations for MEDICLIN AG?
The overall consensus recommendation for MEDICLIN AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the MEDICLIN AG dividend yield?
The MEDICLIN AG dividend yield is 1.35% based on the trailing twelve month period.
Does MEDICLIN AG pay a dividend?
Last year, MEDICLIN AG paid a total dividend of €0.04, and it currently has a trailing dividend yield of 1.35%.Looking ahead, shares in MEDICLIN AG are due to go ex-dividend on 2025-06-05 and the next dividend pay date is 2025-06-10.
When does MEDICLIN AG next pay dividends?
MEDICLIN AG are due to go ex-dividend on 2025-06-05 and the next dividend pay date is 2025-06-10. The historic dividend yield on MEDICLIN AG shares is currently 1.35%.
How do I buy MEDICLIN AG shares?
To buy shares in MEDICLIN AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MEDICLIN AG?
As of the previous close price of €2.96, shares in MEDICLIN AG had a market capitalisation of €140.60m.
Where are MEDICLIN AG shares listed?
Here are the trading details for MEDICLIN AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: MED
What kind of share is MEDICLIN AG?
Based on an overall assessment of its quality, value and momentum MEDICLIN AG is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MEDICLIN AG share price forecast for 2025?
The analyst consensus target price for shares in MEDICLIN AG is €4.70. That is 58.78% above the last closing price of €2.96.
Analysts covering MEDICLIN AG currently have a consensus Earnings Per Share (EPS) forecast of €0.50 for the next financial year.
Find out moreWhat is the trend in the MEDICLIN AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MEDICLIN AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +23.17%.
As of the last closing price of €2.96, shares in MEDICLIN AG were trading +12.96% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MEDICLIN AG PE Ratio?
The MEDICLIN AG PE ratio based on its reported earnings over the past 12 months is 5.89. The shares last closed at €2.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MEDICLIN AG?
MEDICLIN AG's management team is headed by:
- Jan Liersch - CSU
- Volker Hippler - CMG
- Hans Hilpert - VSU
- Tino Fritz - CFO
- Michael Bock - SUB
- Barbara Brosius - SUB
- Julia Dannath-schuh - SUB
- Walburga Erichsmeier - SUB
- Kai Hankeln - SUB
- Rainer Laufs - SUB
- Thomas Mueller - SUB
- Elke Schwan - SUB
- Frauke Schwedt - SUB
- Daniela Sternberg-kinzel - SUB
- Marco Walker - SUB
- Matthias Werner - SUB
- Thomas Witt - SUB
- Cornelia Wolf - SUB